Enhanced efficacy against cervical carcinomas through polymeric micelles physically incorporating the proteasome inhibitor MG132

Treatment of recurrent or advanced cervical cancer is still limited, and new therapeutic choices are needed for improving prognosis and quality of life of patients. Because human papilloma virus (HPV) infection is critical in cervical carcinogenesis, with the E6 and E7 oncogenes of HPV degrading tum...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsumoto, Yoko, Miyamoto, Yuichiro, Cabral, Horacio, Matsumoto, Yu, Nagasaka, Kazunori, Nakagawa, Shunsuke, Yano, Tetsu, Maeda, Daichi, Oda, Katsutoshi, Kawana, Kei, Nishiyama, Nobuhiro, Kataoka, Kazunori, Fujii, Tomoyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968607/
https://www.ncbi.nlm.nih.gov/pubmed/26987571
http://dx.doi.org/10.1111/cas.12926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968607/
https://www.ncbi.nlm.nih.gov/pubmed/26987571
http://dx.doi.org/10.1111/cas.12926

Ejemplares similares